Our GU session ‘The power of precision medicine: Transforming patient outcomes in GU oncology’ will take place on Friday 17 October 2025, 18:00–19:30 CEST.
Heidelberg Auditorium, Hall 6.2, Messe Berlin, Berlin, Germany.
The session will also be live streamed and available via the ESMO platform.
The power of precision medicine: Transforming patient outcomes in GU oncology.
An expert panel – including Dr. Elena Castro, Prof. Dr. Axel Heidenreich, and Dr. Alejo Rodríguez-Vida – will examine key clinical considerations in GU cancer care.18:00-18:05 | Welcome and introductions | Co-chairs: Elena Castro and Patrizia Giannatempo |
18:05-18:25 | Optimising outcomes: Patient-centred care in mHSPC | Alejo Rodríguez-Vida Discussant: Elena Castro |
18:25-18:45 | Timely testing in prostate cancer: Addressing the unmet needs | Axel Heidenreich Discussant: Elena Castro |
18:45-18:50 | Personalising an mUC patient’s journey: A case presentation | Patrizia Giannatempo Discussant: Enrique Grande |
18:50-19:00 | A guide to the guidelines: Strategies for mUC management | Enrique Grande |
19:00-19:10 | Navigating the treatment landscape at second-line to improve patient outcomes | Syed Hussain Discussant: Enrique Grande |
19:10-19:20 | Clinical compass for treatment individualisation in mUC management | Patrizia Giannatempo Discussant: Enrique Grande |
19:20-19:25 | Panel discussion | Patrizia Giannatempo and Syed Hussain; moderated by Enrique Grande |
19:25-19:30 | Final thoughts and closing | Co-chairs: Elena Castro and Patrizia Giannatempo |
The recorded content may not be available in your country. To request access to recordings and session materials, please contact our team.
(Bio) Markers and milestones at the crossroads of mHSPC
Precision oncology: Optimising therapeutic strategies in mHSPC and mCRPC
ⓘ The recorded content may not be available in your country. To request access to recordings and session materials, please contact our team. |
Advancing precision medicine in prostate cancer with the world-leading Gemelli Hospital
At this event, healthcare professionals from across the EMEA region came together to collaborate, exchange real-world insights, and advance evidence-based prostate cancer care in everyday clinical practice.
Our prostate cancer session – ‘(Bio) Markers and milestones at the crossroads of mHPSC’ – explored the latest developments and challenges in the field.
A patient-centric platform designed to support patients throughout their healthcare journey. It provides personalised, high-quality content and services to enhance patient engagement.
By empowering informed, proactive patients, J&J withMe helps improve treatment outcomes.
Learn how this platform can strengthen your patient relationships — explore J&J withMe today!
Register with J&J Medical Cloud to access our full education library, including recordings, slides, and new session announcements.
If you would like to report an Adverse Event (medication side effect) and/or Product Quality Complaint (problem with one of our products), please select one of the links on our contact us page. To submit a medical information request, please visit the designated page.